These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 35380701
1. T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62. Daniel CJ, Pelz C, Wang X, Munks MW, Ko A, Murugan D, Byers SA, Juarez E, Taylor KL, Fan G, Coussens LM, Link JM, Sears RC. Mol Cancer Res; 2022 Jul 06; 20(7):1151-1165. PubMed ID: 35380701 [Abstract] [Full Text] [Related]
4. Stabilization of the c-Myc Protein via the Modulation of Threonine 58 and Serine 62 Phosphorylation by the Disulfiram/Copper Complex in Oral Cancer Cells. Chen GS, Chen SY, Liu ST, Hsieh CC, Lee SP, Huang SM. Int J Mol Sci; 2022 Aug 15; 23(16):. PubMed ID: 36012403 [Abstract] [Full Text] [Related]
5. A germline point mutation in the MYC-FBW7 phosphodegron initiates hematopoietic malignancies. Freie B, Carroll PA, Varnum-Finney BJ, Ramsey EL, Ramani V, Bernstein I, Eisenman RN. Genes Dev; 2024 Apr 17; 38(5-6):253-272. PubMed ID: 38565249 [Abstract] [Full Text] [Related]
6. The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc. Arnold HK, Zhang X, Daniel CJ, Tibbitts D, Escamilla-Powers J, Farrell A, Tokarz S, Morgan C, Sears RC. EMBO J; 2009 Mar 04; 28(5):500-12. PubMed ID: 19131971 [Abstract] [Full Text] [Related]
7. Peroxynitrite promotes serine-62 phosphorylation-dependent stabilization of the oncoprotein c-Myc. Raman D, Chong SJF, Iskandar K, Hirpara JL, Pervaiz S. Redox Biol; 2020 Jul 04; 34():101587. PubMed ID: 32512497 [Abstract] [Full Text] [Related]
9. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain. Hoang AT, Lutterbach B, Lewis BC, Yano T, Chou TY, Barrett JF, Raffeld M, Hann SR, Dang CV. Mol Cell Biol; 1995 Aug 04; 15(8):4031-42. PubMed ID: 7623799 [Abstract] [Full Text] [Related]
10. Altering MYC phosphorylation in the epidermis increases the stem cell population and contributes to the development, progression, and metastasis of squamous cell carcinoma. Wang X, Langer EM, Daniel CJ, Janghorban M, Wu V, Wang XJ, Sears RC. Oncogenesis; 2020 Sep 07; 9(9):79. PubMed ID: 32895364 [Abstract] [Full Text] [Related]
15. Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging. Blyth K, Terry A, Mackay N, Vaillant F, Bell M, Cameron ER, Neil JC, Stewart M. Oncogene; 2001 Jan 18; 20(3):295-302. PubMed ID: 11313958 [Abstract] [Full Text] [Related]
16. Burkitt's lymphoma-associated c-Myc mutations converge on a dramatically altered target gene response and implicate Nol5a/Nop56 in oncogenesis. Cowling VH, Turner SA, Cole MD. Oncogene; 2014 Jul 03; 33(27):3519-27. PubMed ID: 24013231 [Abstract] [Full Text] [Related]
17. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G, Hahn WC, Stukenberg PT, Shenolikar S, Uchida T, Counter CM, Nevins JR, Means AR, Sears R. Nat Cell Biol; 2004 Apr 03; 6(4):308-18. PubMed ID: 15048125 [Abstract] [Full Text] [Related]
20. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer. Lv Z, Wei J, You W, Wang R, Shang J, Xiong Y, Yang H, Yang X, Fu Z. J Transl Med; 2017 Dec 19; 15(1):257. PubMed ID: 29258530 [Abstract] [Full Text] [Related] Page: [Next] [New Search]